$0.8699
0.00981.14%
最終更新: Oct 13, 4:00 PM
$0.8790
0.01892.2%
Benzinga
Benzinga
Benzinga
火曜日, 10 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Allarity Therapeutics (ALLR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $-0.22 | $-0.22 | $-0.23 |
| Actual | $-0.21 | $-0.17 | $-0.21 | $-0.19 |
| Surprise | +16.0% | +22.7% | +4.55% | +17.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $25000 | $320000 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.21 | $-0.22 | $-0.22 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.21 | $-0.25 | 16.0 % |
| Q1 | May 15, 2026 | $-0.17 | $-0.22 | 22.7 % |
| Q4 | Mar 31, 2026 | $-0.21 | $-0.22 | 4.55 % |
| Q3 | Nov 14, 2025 | $-0.19 | $-0.23 | 17.4 % |